Diamant Asset Management Inc. trimmed its holdings in Colgate-Palmolive (NYSE:CL) by 2.6% in the first quarter, Holdings Channel reports. The fund owned 44,190 shares of the company’s stock after selling 1,200 shares during the period. Colgate-Palmolive makes up 3.0% of Diamant Asset Management Inc.’s investment portfolio, making the stock its 7th biggest position. Diamant Asset Management Inc.’s holdings in Colgate-Palmolive were worth $3,029,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank purchased a new position in shares of Colgate-Palmolive in the fourth quarter worth $488,436,000. BlackRock Inc. increased its stake in shares of Colgate-Palmolive by 13.5% in the fourth quarter. BlackRock Inc. now owns 60,648,605 shares of the company’s stock worth $3,609,804,000 after buying an additional 7,236,342 shares during the period. Oregon Public Employees Retirement Fund increased its stake in shares of Colgate-Palmolive by 5,779.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 5,625,533 shares of the company’s stock worth $95,000 after buying an additional 5,529,852 shares during the period. Ceredex Value Advisors LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter worth $71,576,000. Finally, Los Angeles Capital Management & Equity Research Inc. increased its stake in shares of Colgate-Palmolive by 405.4% in the fourth quarter. Los Angeles Capital Management & Equity Research Inc. now owns 1,283,928 shares of the company’s stock worth $76,419,000 after buying an additional 1,029,873 shares during the period. Hedge funds and other institutional investors own 75.99% of the company’s stock.

Shares of Colgate-Palmolive stock opened at $71.69 on Tuesday. The company has a current ratio of 1.07, a quick ratio of 0.74 and a debt-to-equity ratio of 32.25. The firm has a market cap of $61.77 billion, a price-to-earnings ratio of 24.81, a P/E/G ratio of 4.72 and a beta of 0.81. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $72.85.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.67 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.01. The business had revenue of $3.88 billion for the quarter, compared to the consensus estimate of $3.86 billion. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.74 EPS. On average, analysts forecast that Colgate-Palmolive will post 2.83 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $0.43 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date is Wednesday, April 17th. Colgate-Palmolive’s payout ratio is presently 57.91%.

Several research analysts recently commented on the stock. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Monday. Macquarie lifted their target price on shares of Colgate-Palmolive from $65.00 to $72.00 and gave the stock a “neutral” rating in a research note on Monday, April 29th. Morgan Stanley lifted their target price on shares of Colgate-Palmolive from $62.00 to $68.00 and gave the stock an “equal weight” rating in a research note on Monday, April 29th. Jefferies Financial Group lifted their target price on shares of Colgate-Palmolive from $61.00 to $73.00 and gave the stock an “in-line” rating in a research note on Monday, April 29th. They noted that the move was a valuation call. Finally, JPMorgan Chase & Co. raised shares of Colgate-Palmolive from an “underweight” rating to a “neutral” rating and lifted their target price for the stock from $62.00 to $70.00 in a research note on Monday, April 29th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $69.81.

In other Colgate-Palmolive news, CEO Ian M. Cook sold 22,634 shares of the business’s stock in a transaction on Tuesday, February 19th. The shares were sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the transaction, the chief executive officer now directly owns 1,162,793 shares of the company’s stock, valued at approximately $77,104,803.83. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Stephen I. Sadove sold 8,000 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $71.55, for a total transaction of $572,400.00. Following the transaction, the director now directly owns 39,441 shares in the company, valued at $2,822,003.55. The disclosure for this sale can be found here. Over the last three months, insiders have sold 246,149 shares of company stock worth $17,203,908. Insiders own 1.14% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Colgate-Palmolive (CL) is Diamant Asset Management Inc.’s 7th Largest Position” was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://www.watchlistnews.com/colgate-palmolive-cl-is-diamant-asset-management-inc-s-7th-largest-position/3000570.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: What is a Leveraged Buyout (LBO)?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.